Caryn Fenner

Company: Afrigen Biologics (Pty) Ltd

Job title: Executive Director - Messenger Ribonucleic Acid Hub

Seminars:

Fireside Discussion: Leveraging the mRNA Platform to Advance Development & Manufacturability Successfully at Clinical Stages 12:15 pm

What is required to ensure mRNA vaccine development at speed with a coordinated effort?  How to accelerate mRNA vaccine process manufacturing to combat future pandemics? How can we apply learnings to promote global access to mRNA technology that will be key for pandemic preparedness?Read more

day: Day 1 Track 2 AM

Development of a Gonorrhea Vaccine Using the mRNA Platform Established at Afrigen 10:30 am

Overview of mRNA platform established in Afrigen Platform for sustainability with pipeline of disease targets Showcasing mRNA Gonorrhea vaccine as one of the pipeline targets, and early preclinical resultsRead more

day: Day 2 Track 1 AM

Towards Global Access & Equity for mRNA Technology: An Update from Afrigen Biologics 11:30 am

Unlocking mRNA vaccine design, development and production geared to enable LMICs to produce mRNA products Establishing a “green fields” mRNA end to end commercial production process Product innovations for effective, affordable and accessible mRNA vaccines for neglected diseases suitable for LMICs and relevance to pandemic preparednessRead more

day: Day 2 Track 2 AM